Sparrow Pharmaceuticals to Present on HSD-1 Inhibitor Clofutriben (SPI-62) for Polymyalgia Rheumatica at the European Congress of Rheumatology 2024

PORTLAND, Ore.--(BUSINESS WIRE)--Jun 6, 2024--

Related Keywords

Austria ,Vienna ,Wien ,Alexis Feinberg ,David Katz ,Sparrow Pharmaceuticals ,European Congress ,Chief Scientific Officer ,Hydroxysteroid Dehydrogenase Type ,Modulates Prednisolone Immune ,Musculoskeletal Efficacy ,Resorption Biomarkers ,Polymyalgia Rheumatica ,Business Wire ,